Amwise Diagnostics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $10M

  • Investors
  • 4

Amwise Diagnostics General Information

Description

Provider of precision medical service focused on cancer. The company's genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal adverse effects. The company's existing technology can identify patients who have high risk of recurrence or metastasis of breast cancer, allowing timely administration of necessary treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3F., No.40, Sec. 2, Dunhua S. Rd.
  • Da'an Dist.
  • Taipei, 106-83
  • Taiwan
+886 02
Primary Industry
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • 3F., No.40, Sec. 2, Dunhua S. Rd.
  • Da'an Dist.
  • Taipei, 106-83
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amwise Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 25-Feb-2020 $10M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2016 Completed Startup
To view Amwise Diagnostics’s complete valuation and funding history, request access »

Amwise Diagnostics Patents

Amwise Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022225447-A1 Risk assessment method of breast cancer recurrence or metastasis and kit thereof Inactive 20-Apr-2021
EP-3298167-A2 Gene expression profiles and uses thereof in breast cancer Active 19-May-2015
EP-3298167-A4 Gene expression profiles and uses thereof in breast cancer Active 19-May-2015
EP-3298167-B1 Gene expression profiles and uses thereof in breast cancer Inactive 19-May-2015
US-20180298449-A1 Gene expression profiles and uses thereof in breast cancer Inactive 19-May-2015 C12Q1/6886
To view Amwise Diagnostics’s complete patent history, request access »

Amwise Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amwise Diagnostics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Simcere VC-Backed Company Minority
Alibaba Entrepreneurs Fund Corporate Venture Capital Minority
Lippo Karawaci Real Estate Minority
WI Harper Group Venture Capital Minority
To view Amwise Diagnostics’s complete investors history, request access »

Amwise Diagnostics FAQs

  • When was Amwise Diagnostics founded?

    Amwise Diagnostics was founded in 2015.

  • Where is Amwise Diagnostics headquartered?

    Amwise Diagnostics is headquartered in Taipei, Taiwan.

  • What is the size of Amwise Diagnostics?

    Amwise Diagnostics has 25 total employees.

  • What industry is Amwise Diagnostics in?

    Amwise Diagnostics’s primary industry is Laboratory Services (Healthcare).

  • Is Amwise Diagnostics a private or public company?

    Amwise Diagnostics is a Private company.

  • What is Amwise Diagnostics’s current revenue?

    The current revenue for Amwise Diagnostics is .

  • How much funding has Amwise Diagnostics raised over time?

    Amwise Diagnostics has raised $10M.

  • Who are Amwise Diagnostics’s investors?

    Simcere, Alibaba Entrepreneurs Fund, Lippo Karawaci, and WI Harper Group have invested in Amwise Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process